Harnessing social media networks to share information about stem cell research and treatments

To further public understanding of regenerative medicine, EuroStemCell has published lay summaries for all articles from the latest Regenerative Medicine special focus issue.

Like 0 Comment

EuroStemCell have launched a digital platform to accompany the publication of the Regenerative Medicine two-part Special Focus Issue entitled “Regenerative Medicine in Society: Interdisciplinary Perspectives”. The platform presents lay summaries of each article in the issue which are freely available to all in order to engage and educate non-experts on the key issues surrounding regenerative medicine.

You can now read the lay summary for the article entitled “Leveraging social media in the stem cell sector: exploring Twitter's potential as a vehicle for public information campaigns” from Kathleen McNutt & Amy Zarzeczny [1].

Demand has driven the continued growth of unproven stem cell treatments offered in private clinics around the world, despite regulations and restrictions on stem cell use in many countries. Social media offers a tremendous opportunity to use social networks as a way to inform the public about stem cell research and the risks involved with unproven treatments. Recently, a public information campaign using Twitter was designed to explore the potential use of online networks as a way to share evidence-based information and encourage people to engage in discussion about stem cell-related topics.

What questions & challenges are raised? What insight and direction does this give for research policies? To find out, read the full lay summary on the EuroStemCell website here:

The full original article can be accessed here:


[1] McNutt K, Zarzeczny A. Leveraging social media in the stem cell sector: exploring Twitter's potential as a vehicle for public information campaigns. Regen. Med. 12(7), 753–764 (2017).

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.